195 related articles for article (PubMed ID: 34848360)
1. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.
Xu Z; Lin S; Gong J; Feng P; Cao Y; Li Q; Jiang Y; You Y; Tong Y; Wang P
Front Med (Lausanne); 2021; 8():681391. PubMed ID: 34179049
[No Abstract] [Full Text] [Related]
4. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
5. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice.
Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y
J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266
[TBL] [Abstract][Full Text] [Related]
6. Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease.
Ren T; Zhu L; Shen Y; Mou Q; Lin T; Feng H
Food Funct; 2019 Mar; 10(3):1540-1551. PubMed ID: 30785444
[TBL] [Abstract][Full Text] [Related]
7. Lycium barbarum Polysaccharides Promotes Mitochondrial Biogenesis and Energy Balance in a NAFLD Cell Model.
Zhang YN; Guo YQ; Fan YN; Tao XJ; Gao QH; Yang JJ
Chin J Integr Med; 2022 Nov; 28(11):975-982. PubMed ID: 34874519
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
[TBL] [Abstract][Full Text] [Related]
9. [Blueberry attenuates liver injury in metabolic dysfunction-associated liver disease by promoting the expression of mitofilin/Mic60 in human hepatocytes and inhibiting the production of superoxide].
Ren Y; Fan H; Zhu L; Lin T; Ren T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):318-324. PubMed ID: 37087549
[TBL] [Abstract][Full Text] [Related]
10. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
11. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotection of Lycii Fructus Polysaccharide against Oxidative Stress in Hepatocytes and Larval Zebrafish.
Zhang F; Zhang X; Gu Y; Wang M; Guo S; Liu J; Zhang X; Zhao Z; Qian B; Yan Y; Yu L; Xu C; Liu C; Cao F; Qian D; Duan JA
Oxid Med Cell Longev; 2021; 2021():3923625. PubMed ID: 33680282
[TBL] [Abstract][Full Text] [Related]
13. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
14. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease.
Mu JK; Zi L; Li YQ; Yu LP; Cui ZG; Shi TT; Zhang F; Gu W; Hao JJ; Yu J; Yang XX
Biomed Pharmacother; 2021 Oct; 142():112092. PubMed ID: 34449316
[TBL] [Abstract][Full Text] [Related]
15. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
[TBL] [Abstract][Full Text] [Related]
16. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction.
Zhao MG; Sheng XP; Huang YP; Wang YT; Jiang CH; Zhang J; Yin ZQ
Biomed Pharmacother; 2018 Aug; 104():229-239. PubMed ID: 29775890
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
Liang XY; Hong FF; Yang SL
Diabetes Metab Syndr Obes; 2021; 14():1871-1883. PubMed ID: 33953586
[TBL] [Abstract][Full Text] [Related]
18. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis.
Wang YC; Kong WZ; Jin QM; Chen J; Dong L
World J Gastroenterol; 2015 Sep; 21(35):10104-12. PubMed ID: 26401075
[TBL] [Abstract][Full Text] [Related]
19. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
Shi YM; Fu ZH; Zhu CS; Li XP
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
[TBL] [Abstract][Full Text] [Related]
20. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
